Medtronic Affera Mapping and Ablation System with Sphere-9 Catheter achieves endpoints for safety and efficacy, providing promising evidence for the future of atrial fibrillation treatment Life Science Investing News
Late-breaking data show reliable performance of small-diameter defibrillation lead, the Medtronic OmniaSecure Life Science Investing News
Medtronic to announce financial results for its fourth quarter and full fiscal year 2024 Medical Device Investing
Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Ironshore Pharmaceuticals & Development, Inc. for JORNAY PM® for Canada and Latin America Pharmaceutical Investing
Knight Therapeutics Inc. announces voting results from the Annual General Meeting Pharmaceutical Investing
Thermo Fisher Scientific to Present at BofA Securities 2024 Health Care Conference on May 14 Medical Device Investing
